Cargando…
Glycosylation of MUC6 by α1,4‐linked N‐acetylglucosamine enhances suppression of pancreatic cancer malignancy
Biomarkers for early diagnosis of pancreatic cancer are greatly needed, as the high fatality of this cancer is in part due to delayed detection. α1,4‐linked N‐acetylglucosamine (αGlcNAc), a unique O‐glycan specific to gastric gland mucus, is biosynthesized by α1,4‐N‐acetylglucosaminyltransferase (α4...
Autores principales: | Yuki, Atsuko, Fujii, Chifumi, Yamanoi, Kazuhiro, Matoba, Hisanori, Harumiya, Satoru, Kawakubo, Masatomo, Nakayama, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819301/ https://www.ncbi.nlm.nih.gov/pubmed/34808019 http://dx.doi.org/10.1111/cas.15209 |
Ejemplares similares
-
α1,4‐Linked N‐acetylglucosamine suppresses gastric cancer development by inhibiting Mucin‐1‐mediated signaling
por: Fujii, Chifumi, et al.
Publicado: (2022) -
Decreased alpha‐1,4‐linked N‐acetylglucosamine glycosylation in biliary tract cancer progression from biliary intraepithelial neoplasia to invasive adenocarcinoma
por: Okumura, Motohiro, et al.
Publicado: (2020) -
Gastric gland mucin‐specific O‐glycan expression decreases with tumor progression from precursor lesions to pancreatic cancer
por: Ohya, Ayumi, et al.
Publicado: (2017) -
Overexpression and altered glycosylation of MUC1 in malignant mesothelioma
por: Creaney, J, et al.
Publicado: (2008) -
Hypoxic regulation of glycosylation via the N-acetylglucosamine cycle
por: Shirato, Ken, et al.
Publicado: (2011)